UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique

Cancer treatment reviews, 2016-11, Vol.50, p.247-263

2016

Volltextzugriff (PDF)

Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-02, Vol.1138, p.121925-121925, Article 121925

2020

Volltextzugriff (PDF)

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-01, Vol.1104, p.234-239

2019

Volltextzugriff (PDF)

Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2018-07, Vol.1090, p.14-21

2018

Volltextzugriff (PDF)

Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2020-01, Vol.177, p.112871, Article 112871

2020

Volltextzugriff (PDF)

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

International journal of pharmaceutics, 2011-11, Vol.420 (2), p.244-250

2011

Volltextzugriff (PDF)

The role of nuclear receptors in pharmacokinetic drug–drug interactions in oncology

Cancer treatment reviews, 2007-06, Vol.33 (4), p.369-380

2007

Volltextzugriff (PDF)

Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay quantifying olaparib in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-12, Vol.940, p.121-125

2013

Volltextzugriff (PDF)

Effect of Chinese herbs on CYP3A4 activity and expression in vitro

Journal of ethnopharmacology, 2013-09, Vol.149 (2), p.543-549

2013

Volltextzugriff (PDF)

Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-03, Vol.887-888, p.25-34

2012

Volltextzugriff (PDF)

Development and validation of LC–MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-04, Vol.893-894, p.92-100

2012

Volltextzugriff (PDF)

Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-03, Vol.919-920, p.43-51

2013

Volltextzugriff (PDF)

Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2017-01, Vol.1040, p.14-21

2017

Volltextzugriff (PDF)

Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-06, Vol.879 (19), p.1677-1685

2011

Volltextzugriff (PDF)

Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review

Analytica chimica acta, 2010-12, Vol.683 (1), p.21-37

2010

Volltextzugriff (PDF)

Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients

Clinical therapeutics, 2017-08, Vol.39 (8), p.e7-e8

2017

Volltextzugriff (PDF)

Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview

The oncologist (Dayton, Ohio), 2002-12, Vol.7 (6), p.516-530

2002

Volltextzugriff (PDF)

Transposon leads to contamination of clinical pDNA vaccine

Vaccine, 2013-07, Vol.31 (32), p.3274-3280

2013

Volltextzugriff (PDF)

Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

Annals of oncology, 2019-02, Vol.30 (2), p.219-235

2019

Volltextzugriff (PDF)

Future opportunities in preventing cisplatin induced ototoxicity

Cancer treatment reviews, 2006-08, Vol.32 (5), p.390-397

2006

Volltextzugriff (PDF)

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Immuno-oncology technology, 2022-09, Vol.15, p.100089-100089, Article 100089

2022

Volltextzugriff (PDF)

Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-04, Vol.925, p.117-123

2013

Volltextzugriff (PDF)

Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-04, Vol.891-892, p.57-63

2012

Volltextzugriff (PDF)

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?

Cancer treatment reviews, 2013-06, Vol.39 (4), p.305-312

2013

Volltextzugriff (PDF)

Tubuline, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum–gemcitabine chemotherapy

Lung cancer (Amsterdam, Netherlands), 2011-11, Vol.74 (2), p.310-317

2011

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(263)
Mit Volltextzugriff
(281)

Publikationsform

Artikel
(295)
Reviews
(1)

Sprache

Englisch
(296)
Japanisch
(28)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique

Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors

Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling

Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry

Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)

The role of nuclear receptors in pharmacokinetic drug–drug interactions in oncology

Development and validation of a high-performance liquid chromatography–tandem mass spectrometry assay quantifying olaparib in human plasma

Effect of Chinese herbs on CYP3A4 activity and expression in vitro

Development and validation of LC–MS/MS assays for the quantification of E7080 and metabolites in various human biological matrices

Development and validation of LC–MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine

Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography–tandem mass spectrometry

Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine

Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry

Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review

Characterization of Absorption, Metabolism, and Elimination of Niraparib, an Investigational Poly (ADP-Ribose) Polymerase Inhibitor, in Cancer Patients

Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview

Transposon leads to contamination of clinical pDNA vaccine

Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

Future opportunities in preventing cisplatin induced ototoxicity

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Quantification of cabazitaxel, its metabolite docetaxel and the determination of the demethylated metabolites RPR112698 and RPR123142 as docetaxel equivalents in human plasma by liquid chromatography–tandem mass spectrometry

Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Is combination therapy the next step to overcome resistance and reduce toxicities in melanoma?

Tubuline, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum–gemcitabine chemotherapy

Suchergebnisse filtern